PHAR

AS OF

Sep 27 closing price

Price

$8.49

Change

+$0.46 (+5.73%)

Capitalization

536.86M

25 days until earnings call

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

PHAR Stock PHAR is expected to report earnings to rise+104% to 1 cents per share on August 01

GET DAILY SIGNALS

Get AI intraday signals

A.I.dvisor
at Tickeron.com

Buy or Sell

View Daily Signals

08/01/24

PHAR - Pharming Group NV

Q2'24

Est.

$0.01

Q1'24

Missed

by $0.20

Q4'23

Missed

by $0.04

Q3'23

Beat

by $0.13

Q2'23

Beat

by $0.11

The last earnings report on March 31 showed earnings per share of -19 cents, missing the estimate of 1 cents. P/B Ratio (2.557) is normal, around the industry mean (12.411). P/E Ratio (0.000) is within average values for comparable stocks, (150.866). PHAR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.490). Dividend Yield (0.000) settles around the average of (0.066) among similar stocks. P/S Ratio (2.206) is also within normal values, averaging (218.033). With 280 shares outstanding, the current market capitalization sits at 554.00M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for PHAR (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Darwinweg 24

Phone

+31 715247400

Employees

332

Web

https://www.pharming.com